DE69017455T2 - Pharmazeutisches produkt für die behandlung von sepsis. - Google Patents

Pharmazeutisches produkt für die behandlung von sepsis.

Info

Publication number
DE69017455T2
DE69017455T2 DE69017455T DE69017455T DE69017455T2 DE 69017455 T2 DE69017455 T2 DE 69017455T2 DE 69017455 T DE69017455 T DE 69017455T DE 69017455 T DE69017455 T DE 69017455T DE 69017455 T2 DE69017455 T2 DE 69017455T2
Authority
DE
Germany
Prior art keywords
antibody
sepsis
specific
treatment
lps
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69017455T
Other languages
English (en)
Other versions
DE69017455D1 (de
Inventor
Mark Bodmer
Steven Opal
Alan Cross
Jerald Sadoff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB Celltech Ltd
Original Assignee
Celltech R&D Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celltech R&D Ltd filed Critical Celltech R&D Ltd
Application granted granted Critical
Publication of DE69017455D1 publication Critical patent/DE69017455D1/de
Publication of DE69017455T2 publication Critical patent/DE69017455T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
DE69017455T 1989-08-10 1990-08-10 Pharmazeutisches produkt für die behandlung von sepsis. Expired - Fee Related DE69017455T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898918232A GB8918232D0 (en) 1989-08-10 1989-08-10 Pharmaceutical product for the treatment of septic shock
PCT/US1990/004434 WO1991001755A1 (en) 1989-08-10 1990-08-10 Pharmaceutical product for the treatment of sepsis

Publications (2)

Publication Number Publication Date
DE69017455D1 DE69017455D1 (de) 1995-04-06
DE69017455T2 true DE69017455T2 (de) 1995-06-29

Family

ID=10661418

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69017455T Expired - Fee Related DE69017455T2 (de) 1989-08-10 1990-08-10 Pharmazeutisches produkt für die behandlung von sepsis.

Country Status (10)

Country Link
EP (1) EP0486609B1 (de)
JP (1) JPH05505592A (de)
AT (1) ATE119043T1 (de)
AU (2) AU651320B2 (de)
DE (1) DE69017455T2 (de)
DK (1) DK0486609T3 (de)
ES (1) ES2071827T3 (de)
GB (2) GB8918232D0 (de)
WO (1) WO1991001755A1 (de)
ZA (1) ZA906345B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2138662T3 (es) * 1993-06-03 2000-01-16 Therapeutic Antibodies Inc Produccion de fragmentos de anticuerpos.
AU7194894A (en) * 1993-07-20 1995-02-20 Sumio Arai Endotoxin neutralizer
AU2356095A (en) * 1994-04-20 1995-11-29 U.S. Department Of The Army Vaccine against gram-negative bacterial infections
US6858211B1 (en) * 1998-07-20 2005-02-22 The United States Of America As Represented By The Department Of Health And Human Services Vaccines against Escherichia coli O157 infection
DE19913707A1 (de) * 1999-03-26 2000-10-05 Privates Inst Bioserv Gmbh Immunadsorber zur Sepsistherapie
EP1348443A4 (de) * 2000-12-08 2005-07-06 Takeda Pharmaceutical Kombinationsmedikamente
EP1819731A4 (de) 2004-12-08 2013-02-13 Immunomedics Inc Verfahren und zusammensetzung zur immuntherapie und für den nachweis von entzündungs- und dysregulatorischen immunerkrankungen, infektionserkrankungen, pathologischer angiogenese und krebs

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL81370A (en) * 1986-02-07 1991-06-30 Genetic Systems Corp Pharmaceutical and diagnostic compositions comprising a plurality of human monoclonal antibodies for the treatment of bacterial diseases,methods for the preparation of the compositions and antibodies and kits containing said compositions
NZ229922A (en) * 1988-07-18 1992-04-28 Chiron Corp Monoclonal antibodies specifically binding cachectin (tumor necrosis factor) and compositions
EP0355067A1 (de) * 1988-08-19 1990-02-21 Celltech Limited Arzneimittel gegen bösartige Gewebeneubildung
SG43205A1 (en) * 1988-12-19 1997-10-17 American Cyanamid Co A method for the treatment of endotoxic shock in a mammal

Also Published As

Publication number Publication date
EP0486609B1 (de) 1995-03-01
ZA906345B (en) 1992-04-29
DK0486609T3 (da) 1995-05-08
GB8918232D0 (en) 1989-09-20
ATE119043T1 (de) 1995-03-15
EP0486609A1 (de) 1992-05-27
AU7590694A (en) 1995-01-27
GB2251187A (en) 1992-07-01
DE69017455D1 (de) 1995-04-06
GB2251187B (en) 1993-06-23
GB9202615D0 (en) 1992-03-25
AU6350090A (en) 1991-03-11
ES2071827T3 (es) 1995-07-01
JPH05505592A (ja) 1993-08-19
AU651320B2 (en) 1994-07-21
WO1991001755A1 (en) 1991-02-21

Similar Documents

Publication Publication Date Title
NO901679D0 (no) Fremgangsmaate for fremstilling av et produkt analogt til glassaalen og produktet oppnaadd paa den maaten.
ES2066603T3 (es) Fungicidas de 3-difluorometilpirazolcarboxamida.
DE3784720D1 (de) Produkt, praeparat und methode zum bekaempfen der allergien.
NO953710D0 (no) Rehydrert produkt og fremgangsmåte for fremstilling derav
DE69329344D1 (de) Spezifische modulationen des immunsystems
DK614987D0 (da) Syntetiske htlv-iii peptider, praeparater og anvendelser deraf
NO884139D0 (no) Behandlingsparameter-generator for syntetisk aperturradar.
FI950062A (fi) Proteiinien foroaktivaatio konjugaatiotarkoituksia varten
DE69017455T2 (de) Pharmazeutisches produkt für die behandlung von sepsis.
DE3650088T2 (de) Inhibin und dessen reinigung.
ATE6032T1 (de) Biologisch aktive substanzen, deren herstellung aus menschlichem kasein und zubereitungen, die sie enthalten.
DK159114C (da) Benzyldihydrofuropyridinderivater og praeparater indeholdende disse forbindelser
DK199779A (da) Renset antigen til undersoegelse for neisseria gonorrhoeae antistoffer
BR9202323A (pt) Gel e processo para a sua preparacao
BR0015287A (pt) Moléculas recombinantes de fusão
NO913817D0 (no) Fremgangsmaate og produkt for tekstilfarging.
NO913078L (no) Oekt proteinproduksjon i dyr.
ES2092514T3 (es) Conjugados de anticuerpos de dominio variable.
FI961584A (fi) C-reaktiivisista proteiinifragmenteista johdetut oligopeptidit
FI971879A0 (fi) Allogeenisten ja ksenogeenisten proteiinien vasta-aineet, niiden käyttö diagnoosissa ja hoidossa ja menetelmät niiden määrittämiseksi
ES2067058T3 (es) Tratamiento de carnes.
DE69111429D1 (de) Monoklonale antikörper, die einen unterschied zwischen nativproteinen und proteinen mit einer modifizierten sequenz machen.
ES2063057T3 (es) Esteres aromaticos de antibioticos macrolidicos y lincosamidicos, su procedimiento de preparacion y composiciones farmaceuticas y cosmeticas que los contienen.
IT1195272B (it) Sintesi del daunosamina cloridrato e prodotti intermedi usati nella sua preparazione
DE69012505D1 (de) Diätprodukt.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee